Surgical Site Infection Leading to Gangrene and Amputation After
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Clinical Practice Guideline for Limb Salvage Or Early Amputation
Limb Salvage or Early Amputation Evidence-Based Clinical Practice Guideline Adopted by: The American Academy of Orthopaedic Surgeons Board of Directors December 6, 2019 Endorsed by: Please cite this guideline as: American Academy of Orthopaedic Surgeons. Limb Salvage or Early Amputation Evidence-Based Clinical Practice Guideline. https://www.aaos.org/globalassets/quality-and-practice-resources/dod/ lsa-cpg-final-draft-12-10-19.pdf Published December 6, 2019 View background material via the LSA CPG eAppendix Disclaimer This clinical practice guideline was developed by a physician volunteer clinical practice guideline development group based on a formal systematic review of the available scientific and clinical information and accepted approaches to treatment and/or diagnosis. This clinical practice guideline is not intended to be a fixed protocol, as some patients may require more or less treatment or different means of diagnosis. Clinical patients may not necessarily be the same as those found in a clinical trial. Patient care and treatment should always be based on a clinician’s independent medical judgment, given the individual patient’s specific clinical circumstances. Disclosure Requirement In accordance with AAOS policy, all individuals whose names appear as authors or contributors to this clinical practice guideline filed a disclosure statement as part of the submission process. All panel members provided full disclosure of potential conflicts of interest prior to voting on the recommendations contained within this clinical practice guideline. Funding Source This clinical practice guideline was funded exclusively through a research grant provided by the United States Department of Defense with no funding from outside commercial sources to support the development of this document. -
Soft Tissue Calcification and Ossification
Soft Tissue Calcification and Ossification Soft-tissue Calcification Metastatic Calcification =deposit of calcium salts in previously normal tissue (1) as a result of elevation of Ca x P product above 60-70 (2) with normal Ca x P product after renal transplant Location:lung (alveolar septa, bronchial wall, vessel wall), kidney, gastric mucosa, heart, peripheral vessels Cause: (a)Skeletal deossification 1.1° HPT 2.Ectopic HPT production (lung / kidney tumor) 3.Renal osteodystrophy + 2° HPT 4.Hypoparathyroidism (b)Massive bone destruction 1.Widespread bone metastases 2.Plasma cell myeloma 3.Leukemia Dystrophic Calcification (c)Increased intestinal absorption =in presence of normal serum Ca + P levels secondary to local electrolyte / enzyme alterations in areas of tissue injury 1.Hypervitaminosis D Cause: 2.Milk-alkali syndrome (a)Metabolic disorder without hypercalcemia 3.Excess ingestion / IV administration of calcium salts 1.Renal osteodystrophy with 2° HPT 4.Prolonged immobilization 2.Hypoparathyroidism 5.Sarcoidosis 3.Pseudohypoparathyroidism (d)Idiopathic hypercalcemia 4.Pseudopseudohypoparathyroidism 5.Gout 6.Pseudogout = chondrocalcinosis 7.Ochronosis = alkaptonuria 8.Diabetes mellitus (b) Connective tissue disorder 1.Scleroderma 2.Dermatomyositis 3.Systemic lupus erythematosus (c)Trauma 1.Neuropathic calcifications 2.Frostbite 3.Myositis ossificans progressiva 4.Calcific tendinitis / bursitis (d)Infestation 1.Cysticercosis Generalized Calcinosis 2.Dracunculosis (guinea worm) (a)Collagen vascular disorders 3.Loiasis 1.Scleroderma -
Hyperplasia (Growth Factors
Adaptations Robbins Basic Pathology Robbins Basic Pathology Robbins Basic Pathology Coagulation Robbins Basic Pathology Robbins Basic Pathology Homeostasis • Maintenance of a steady state Adaptations • Reversible functional and structural responses to physiologic stress and some pathogenic stimuli • New altered “steady state” is achieved Adaptive responses • Hypertrophy • Altered demand (muscle . hyper = above, more activity) . trophe = nourishment, food • Altered stimulation • Hyperplasia (growth factors, . plastein = (v.) to form, to shape; hormones) (n.) growth, development • Altered nutrition • Dysplasia (including gas exchange) . dys = bad or disordered • Metaplasia . meta = change or beyond • Hypoplasia . hypo = below, less • Atrophy, Aplasia, Agenesis . a = without . nourishment, form, begining Robbins Basic Pathology Cell death, the end result of progressive cell injury, is one of the most crucial events in the evolution of disease in any tissue or organ. It results from diverse causes, including ischemia (reduced blood flow), infection, and toxins. Cell death is also a normal and essential process in embryogenesis, the development of organs, and the maintenance of homeostasis. Two principal pathways of cell death, necrosis and apoptosis. Nutrient deprivation triggers an adaptive cellular response called autophagy that may also culminate in cell death. Adaptations • Hypertrophy • Hyperplasia • Atrophy • Metaplasia HYPERTROPHY Hypertrophy refers to an increase in the size of cells, resulting in an increase in the size of the organ No new cells, just larger cells. The increased size of the cells is due to the synthesis of more structural components of the cells usually proteins. Cells capable of division may respond to stress by undergoing both hyperrtophy and hyperplasia Non-dividing cell increased tissue mass is due to hypertrophy. -
NAIL DISEASES and NAIL HEALTH Your Nails Can Tell You a Lot About Your Health
Dermatology Patient Education NAIL DISEASES AND NAIL HEALTH Your nails can tell you a lot about your health. Nail diseases and warning signs of other health problems appear on the nails. Your nails also reveal whether you are taking good care them. Good nail care is important because it can help prevent many common nail problems. NAIL DISEASES The skin around our nails and the tissue beneath are susceptible to many diseases. If you see any of the following, promptly see a dermatologist. Early diagnosis and proper treatment offer the best outcome. If allowed to progress, nail disease can be challenging to treat. Melanoma under the nail • Dark spot or streak Melanoma (skin cancer): Nail streaks are common in people of color. While many nail streaks are harmless, it is important to know that about 30% to 40% of melanomas that occur in people of color develop under a nail. While melanoma under the nail is more common in people of color, anyone can get melanoma under a nail. If your nail has a dark streak or spot and you do not remember injuring the nail, promptly see a dermatologist. When caught early, melanoma can be cured. • Growth Skin cancer: Many different types of skin cancer, including melanoma and Squamous cell carcinoma, can form under or around a nail. If you see a growth under or around your nail, promptly see a dermatologist. Your dermatologist can tell you whether the growth should be removed. Wart: A growth on the skin surrounding a nail is often a wart. Warts are common on the hands and feet. -
Reducing Amputation Rates After Severe Frostbite JENNIFER TAVES, MD, and THOMAS SATRE, MD, University of Minnesota/St
FPIN’s Help Desk Answers Reducing Amputation Rates After Severe Frostbite JENNIFER TAVES, MD, and THOMAS SATRE, MD, University of Minnesota/St. Cloud Hospital Family Medicine Resi- dency Program, St. Cloud, Minnesota Help Desk Answers pro- Clinical Question in the tPA plus iloprost group with severe vides answers to questions submitted by practicing Is tissue plasminogen activator (tPA) effec- disease and only three and nine digits in the family physicians to the tive in reducing digital amputation rates in other treatment arms. Thus, no conclusions Family Physicians Inquiries patients with severe frostbite? can be reached about the effect of tPA plus Network (FPIN). Members iloprost compared with iloprost alone. of the network select Evidence-Based Answer questions based on their A 2007 retrospective cohort trial evalu- relevance to family medi- In patients with severe frostbite, tPA plus a ated the use of tPA in six patients with severe cine. Answers are drawn prostacyclin may be used to decrease the risk of frostbite.2 After rapid rewarming, patients from an approved set of digital amputation. (Strength of Recommen- underwent digital angiography, and those evidence-based resources and undergo peer review. dation [SOR]: B, based on a single randomized with significant perfusion defects received controlled trial [RCT].) tPA can be used alone intraarterial tPA (0.5 to 1 mg per hour IV The complete database of evidence-based ques- and is associated with lower amputation rates infusion) and heparin (500 units per hour tions and answers is compared with local wound care. (SOR: C, IV infusion) for up to 48 hours. Patients who copyrighted by FPIN. -
A RARE PRESENTATION of INGROWN TOE NAIL *Alagar Samy R
CIBTech Journal of Surgery ISSN: 2319-3875 (Online) An Open Access, Online International Journal Available at http://www.cibtech.org/cjs.htm 2015 Vol. 4 (1) January-April, pp.24-27/Samy Case Report A RARE PRESENTATION OF INGROWN TOE NAIL *Alagar Samy R. ESIC Medical College and Hospital, Coimbatore, Tamilnadu, India *Author for Correspondence ABSTRACT Onychocryptosis or ingrown toenail is a very common pathology of the toenail unit, chiefly affecting adolescents and young adults. The ingrown toenail is responsible for disabling complaints like pain and difficulty in walking. It is associated with significant morbidity, hampering the quality of life as it interferes with sporting activities, school, or work. It principally occurs in the hallux. It is ascribed to poor trimming of the nails in combination with local pressure due to ill-fitting footwear, hyperhidrosis, poor foot hygiene and nail abnormalities. Pain, swelling and discharge are the main clinical features. Four stages of the condition have been described. Diagnosis is usually evident, but it should be differentiated from subungual exostosis and tumors of the nail bed (James et al., 2006). I report a case of in grown toe nail involving right great toe with a swelling in the same toe with occasional pain. There was no history of trauma or any co morbid illness. Hence the right great toe nail with a swelling excised intoto. The Histopathological examination revealed only chronic inflammation. The post operative period was uneventful and discharged on third post operative period. It is being presented for its rarity. Keywords: Onychocryptosis, Hallux, Ingrown, Avulsion INTRODUCTION Onychocryptosis or ingrown toenail is a very common pathology of the toenail unit, chiefly affecting adolescents and young adults. -
Department of Veterans Affairs 8320-01
This document is scheduled to be published in the Federal Register on 02/22/2013 and available online at http://federalregister.gov/a/2013-04134, and on FDsys.gov DEPARTMENT OF VETERANS AFFAIRS 8320-01 38 CFR Part 17 RIN 2900-AO21 Criteria for a Catastrophically Disabled Determination for Purposes of Enrollment AGENCY: Department of Veterans Affairs. ACTION: Proposed rule. SUMMARY: The Department of Veterans Affairs (VA) proposes to amend its regulation concerning the manner in which VA determines that a veteran is catastrophically disabled for purposes of enrollment in priority group 4 for VA health care. The current regulation relies on specific codes from the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and Current Procedural Terminology (CPT®). We propose to state the descriptions that would identify an individual as catastrophically disabled, instead of using the corresponding ICD-9-CM and CPT® codes. The revisions would ensure that our regulation is not out of date when new versions of those codes are published. The revisions would also broaden some of the descriptions for a finding of catastrophic disability. Additionally, we would eliminate the Folstein Mini Mental State Examination (MMSE) as a criterion for determining whether a veteran meets the definition of catastrophically disabled, because we have determined that the MMSE is no longer a necessary clinical assessment tool. DATES: Comments on the proposed rule must be received by VA on or before [Insert date 60 days after date of publication in the FEDERAL REGISTER]. ADDRESSES: Written comments may be submitted through http://www.regulations.gov; by mail or hand-delivery to the Director, Regulations Management (02REG), Department of Veterans Affairs, 810 Vermont Avenue, NW, Room 1068, Washington, DC 20420; or by fax to (202) 273-9026. -
Acquired Tumors Arising from Congenital Hypertrophy of the Retinal Pigment Epithelium
CLINICAL SCIENCES Acquired Tumors Arising From Congenital Hypertrophy of the Retinal Pigment Epithelium Jerry A. Shields, MD; Carol L. Shields, MD; Arun D. Singh, MD Background: Congenital hypertrophy of the retinal lacunae in all 5 patients. The CHRPE ranged in basal di- pigment epithelium (CHRPE) is widely recognized to ameter from 333mmto13311 mm. The size of the el- be a flat, stationary condition. Although it can show evated lesion ranged from 23232mmto83834 mm. minimal increase in diameter, it has not been known to The nodular component in all cases was supplied and spawn nodular tumor that is evident ophthalmoscopi- drained by slightly prominent, nontortuous retinal blood cally. vessels. Yellow retinal exudation occurred adjacent to the nodule in all 5 patients and 1 patient developed a second- Objectives: To report 5 cases of CHRPE that gave rise ary retinal detachment. Two tumors that showed progres- to an elevated lesion and to describe the clinical features sive enlargement, increasing exudation, and progressive of these unusual nodules. visual loss were treated with iodine 125–labeled plaque brachytherapy, resulting in deceased tumor size but no im- Methods: Retrospective medical record review. provement in the visual acuity. Results: Of 5 patients with a nodular lesion arising from Conclusions: Congenital hypertrophy of the retinal pig- CHRPE, there were 4 women and 1 man, 4 whites and 1 ment epithelium can spawn a nodular growth that slowly black. Three patients were followed up for typical CHRPE enlarges, attains a retinal blood supply, and causes exuda- for longer than 10 years before the tumor developed; 2 pa- tiveretinopathyandchroniccystoidmacularedema.Although tients were recognized to have CHRPE and the elevated no histopathologic evidence is yet available, we believe that tumor concurrently. -
Lower Limb Amputation Booklet
A Resource Guide For Lower Limb Amputation Table of Contents Reasons for Amputation . 3 Emotional Adjustments to Amputation . 4 Caring for your Residual Limb . 6 Skin Care Shaping Contracture Management Pressure Relief Sound Limb Preservation Skin Problems Associated with Amputation . 8 Phantom Limb Sensation/Pain . 10 Physical Therapy Following Amputation . 12 Stretches Exercises Preparing for Prosthetic Evaluation . 18 Prosthetic Options . 19 Socket Suspension Knee Feet Caring for your Prosthetic . .. 23 Resources . 24 Websites . 26 Reasons for Amputation There are many reasons for amputations; these are some of the more common causes: Poor Circulation The most common reason for amputation is peripheral artery disease, which leads to poor circulation due to narrowing of the arteries . Without blood flowing throughout the entire limb, the tissues are deprived of oxygen and nutrients . Without oxygen and nutrients, the tissue may begin to die, and this may lead to infection . If the infection becomes too severe, there may be need for amputation . Non-healing wounds or infection People with decreased sensation in the lower extremities may develop wounds and be unaware of these wounds until the wound site has become severe and even infected . If the wound is not responding to antibiotics, the wound may become too severe and there may be need for amputation . Trauma Many types of trauma may result in limb loss, these include, but are not limited to: » Motor vehicle accident » Serious burn » Machinery Accidents » Severe fractures due to falls » Frostbite The most important aspect of many health concerns is prevention . If you have lost a limb due to complications with impaired sensation or circulation, you are at a higher risk for further injury, or new injury to your sound, or intact, limb . -
Chapter 1 Cellular Reaction to Injury 3
Schneider_CH01-001-016.qxd 5/1/08 10:52 AM Page 1 chapter Cellular Reaction 1 to Injury I. ADAPTATION TO ENVIRONMENTAL STRESS A. Hypertrophy 1. Hypertrophy is an increase in the size of an organ or tissue due to an increase in the size of cells. 2. Other characteristics include an increase in protein synthesis and an increase in the size or number of intracellular organelles. 3. A cellular adaptation to increased workload results in hypertrophy, as exemplified by the increase in skeletal muscle mass associated with exercise and the enlargement of the left ventricle in hypertensive heart disease. B. Hyperplasia 1. Hyperplasia is an increase in the size of an organ or tissue caused by an increase in the number of cells. 2. It is exemplified by glandular proliferation in the breast during pregnancy. 3. In some cases, hyperplasia occurs together with hypertrophy. During pregnancy, uterine enlargement is caused by both hypertrophy and hyperplasia of the smooth muscle cells in the uterus. C. Aplasia 1. Aplasia is a failure of cell production. 2. During fetal development, aplasia results in agenesis, or absence of an organ due to failure of production. 3. Later in life, it can be caused by permanent loss of precursor cells in proliferative tissues, such as the bone marrow. D. Hypoplasia 1. Hypoplasia is a decrease in cell production that is less extreme than in aplasia. 2. It is seen in the partial lack of growth and maturation of gonadal structures in Turner syndrome and Klinefelter syndrome. E. Atrophy 1. Atrophy is a decrease in the size of an organ or tissue and results from a decrease in the mass of preexisting cells (Figure 1-1). -
Amputation Explained Download
2 Amputation Explained CONTENTS About Amputation 03 How Common Are Amputations? 03 General Causes Explained 04 Outlook 06 Complications of Amputation 06 Psychological Impact of Amputation 07 Lower and Upper Limb Amputations 09 How an Amputation is Performed 10 Pre-Operative Assessment 10 Surgery 11 Recovering from Amputation 12 Going Home 15 Contact Us 16 About Amputation This leaflet is part of a series produced by Blesma for your general information. It is designed for anyone scheduled for amputation or further amputations, but is useful for anyone who has had surgery to remove a limb or limbs, or part of a limb or limbs. It is hoped that this information will allow people to monitor their own health and seek early advice and intervention from an appropriate medical practitioner. Any questions brought up by this leaflet should be raised with a doctor. How Common Are Amputations? Between 5,000 and 6,000 major limb amputations are carried out in the UK every year. The most common reason for amputation is a loss of blood supply to the affected limb (critical ischemia), which accounts for 70 per cent of lower limb amputations. Trauma is the most common reason for upper limb amputations, and accounts for 57 per cent. People with either Type 1 or Type 2 diabetes are particularly at risk, and are 15 times more likely to need an amputation than the general population. This is because diabetes leads to high blood glucose levels that can damage blood vessels, leading to a restriction in blood supply. More than half of all amputations are performed in people aged 70 or over, while men are twice as likely to need an amputation as women. -
Osteochondrosis – Primary Epiphyseal (Articular/Subchondral) Lesion Can Heal Or Can Progress
60 120 180 1 distal humeral condyles 2 medial epicondyle 3 proximal radial epiphysis 4 anconeal process Lab Ret study N=1018 . Normal . Affected . Total 688 (67.6%) . Total 330 (32.4%) . Male 230 (62.2%) . Male 140 (37.8%) . Female 458 (70.7%) . Female 190 (29.3%) Affected dogs N=330 1affected site - 250 (75.7%) 2 affected sites - 68 (20.6%) 3 affected sites - 12 (3.6%) immature skeletal diseases denis novak technique for skeletal radiography tissue < 12 cm “non-grid” (“table-top”) technique “high detail” system radiation safety diagnosis X – rays examination Ultrasound CT bilateral lesions - clinical signs ? unilateral present > one type of lesion 2ry arthrosis Common Osteochondrosis – primary epiphyseal (articular/subchondral) lesion can heal or can progress Osteochondritis dissecans – free articular fragment will progress Arthrosis Osteochondrosis talus / tarsus Lumbosacral OCD Lumbosacral OCD Inflammatory diseases Panosteitis – non infectious Hypertrophic osteodystrophy (HOD) – perhaps infectious Osteomyelitis - infectious Panosteitis New medullary bone Polyostotic Multiple lesions in one bone Symmetrical or nonsymmetrical Sclerotic pattern B I L A T E R A L periosteal new bone forms with chronicity Cross sections of a tibia different locations Hypertrophic osteodystrophy (HOD) Dogs are systemically ill, febrile, anorectic, reluctant to walk most will recover Radiographic changes of HOD . Polyostotic . Metaphyseal . Symmetrical . Changes of lesion Early Mid Late lytic “plates” in acute case HOD - 4 m ret – lesions are present